Financials
- Market Capitalization 1.54 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2145 | GHRS GH Research PLC - Ordinary Shares | 26.35 USD | +3.94% | -2.73% | +24.47% | +86.09% | 1.63 B USD | ||
| 2168 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.66 USD | +5.20% | -14.76% | -2.75% | +113.58% | 1.63 B USD | ||
| 2173 | AVBP ArriVent BioPharma, Inc. - Common Stock | 32.90 USD | -2.20% | -5.27% | +7.10% | +50.02% | 1.53 B USD | ||
| 2189 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 20.27 USD | -0.69% | +7.76% | +7.53% | +112.03% | 1.49 B USD |
Frequently asked questions about Septerna, Inc. - Common Stock
What is the Septerna, Inc. - Common Stock stock price today?
The current price of Septerna, Inc. - Common Stock (SEPN) is 34.26. Over the past 24 hours, the stock has changed by -0.29%. Follow the SEPN chart for real-time price dynamics.
What is the stock ticker of Septerna, Inc. - Common Stock?
Septerna, Inc. - Common Stock trades under the ticker SEPN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Septerna, Inc. - Common Stock stock going up?
SEPN has changed by -5.49% over the last week, -5.54% over the last month, and +55.66% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Septerna, Inc. - Common Stock net income for the last quarter?
Septerna, Inc. - Common Stock reported net income of -8.64 M for the last quarter. The previous quarter showed -10.74 M, which means net income changed by +19.57%.
How many employees does Septerna, Inc. - Common Stock have?
As of the latest available data, Septerna, Inc. - Common Stock has 130 employees. Workforce size can provide additional context about the company's scale and operations.
What is Septerna, Inc. - Common Stock EBITDA?
Septerna, Inc. - Common Stock EBITDA is -12.9 M, and its EBITDA margin is -48.64%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Septerna, Inc. - Common Stock stock?
You can buy Septerna, Inc. - Common Stock (SEPN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Septerna, Inc. - Common Stock stock?
Investing in Septerna, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SEPN chart and related analysis on metatrader.com as part of your research.